| 词条 | Biostrophin |
| 释义 |
}}Biostrophin is a drug which may serve as a vehicle for gene therapy, in the treatment of Duchenne and Becker muscular dystrophy.[1] As mutations in the gene which codes for the protein dystrophin is the underlying defect responsible for both disorders, biostrophin will deliver a genetically-engineered, functional copy of the gene at the molecular level to affected muscle cells.[1] Dosage, as well as a viable means for systemic release of the drug in patients, is currently being investigated with the use of both canine and primate animal models.[2] Biostrophin is being manufactured by Asklepios BioPharmaceuticals, Inc., with funding provided by the Muscular Dystrophy Association.[3] See alsoOther drugs for Duchenne muscular dystrophy
References1. ^1 {{cite journal |pmid=16391721 |date=Oct 2005 |vauthors=Khurdayan VK, Bozzo J, Prous JR |title=Chronicles in drug discovery |volume=18 |issue=8 |pages=517–522 |issn=0214-0934 |journal=Drug News & Perspectives |doi=10.1358/dnp.2005.18.8.953409}} 2. ^http://www.ncbiotech.org/news_and_events/industry_news/duchenne.html Dec 2006 {{webarchive |url=https://web.archive.org/web/20071017190839/http://www.ncbiotech.org/news_and_events/industry_news/duchenne.html |date=October 17, 2007 }} 3. ^{{cite news|url=http://www.businesswire.com/news/home/20060928005134/en/Asklepios-Biopharmaceutical-Announces-Cross-License-GlaxoSmithKline|title=Asklepios Biopharmaceutical, Inc. Announces Cross License with GlaxoSmithKline|date=2006-09-28}} External links
2 : Muscular dystrophy|Genetic engineering |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。